Carisoprodol
Product Images NDC 10544-132

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 10544-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

350mg 30ct (Label Carisoprodol Tabs 350mg Bpi(10544 132 30) West Ward(0143 9749 10) Rev0)

350mg 30ct (Label Carisoprodol Tabs 350mg Bpi(10544 132 30) West Ward(0143 9749 10) Rev0)
Carisoprodol Tablets USP 350 mg bottle label by Blenheim Pharmacal, Inc. The label indicates a 30 tablet bottle with prescription only status. It includes storage instructions, federal caution, and identifiers such as NDC 10544-132-30, manufacturer code, and lot and expiration date placeholders. Barcodes appear on both sides of the label.*
FDA Label Image

Structure (Carisoprodol Tablets 1)

Structure (Carisoprodol Tablets 1)
Chemical structure of Carisoprodol showing its molecular formula with functional groups and atom connectivity as part of the drug's active ingredient representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.